No insider purchase over the last 90 days. The latest, by Snyder Craig A., was filed 30 May 2023.
This page follows insider dealings at Greenlane Holdings, Inc. as filed with SEC (Form 4), a company from the Retail & Commerce sector. 1 insider has disclosed 2 filings since 23 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
For context, the typical company on the same exchange (median of 3,167 companies) published 24 filings over the same period, against 2 filings here. Our records for Greenlane Holdings, Inc. go back to 2019, with 13 purchases and 76 sales on the open market in total. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 4.4 m USD and net income of -85.6 m USD.
There has been no open-market purchase by an insider of Greenlane Holdings, Inc. for at least a year.
For comparison within the same sector, see the insider buying recorded at Rusta AB (publ) and Puuilo Oyj. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 288 declarations
Greenlane Holdings, Inc. (NASDAQ: GNLN) is a U.S.-listed company traded on the Nasdaq market in the United States. For French-speaking investors, Greenlane is best understood as a specialized distribution and brand-platform business focused on cannabis accessories, vaporization products, child-resistant packaging and related lifestyle products. The company was formed in connection with its April 2019 initial public offering, making it a relatively recent public company, although its operating history predates the IPO through the legacy operating business. Greenlane is headquartered in Boca Raton, Florida, United States.
From a business-model perspective, Greenlane has positioned itself as a “house of brands” and distribution platform serving the ancillary cannabis and vaping ecosystem. Its portfolio has included premium accessories, rolling papers, grinders, glass products, packaging solutions and retail concepts. The company also sells through direct-to-consumer and digital channels, which broadens its reach beyond wholesale relationships. That mix gives Greenlane exposure to specialty retailers, dispensaries, cannabis operators and end consumers, depending on the product line and geography.
In competitive terms, Greenlane operates in a fragmented category where brand differentiation, product breadth, distribution relationships and regulatory compliance matter. Its customer base has historically included multi-state operators, single-state operators and licensed Canadian producers, reflecting a cross-border commercial footprint in North America. Greenlane’s latest public filings also show that, as of 2024, management reported two operating segments: Consumer Goods and Industrial Goods. That segment structure suggests a more focused internal reporting framework and a continued effort to manage the portfolio with clearer accountability.
Recent company developments have centered on capital structure management and operational repositioning. In July 2024, Greenlane completed a reverse stock split and resumed trading on Nasdaq on an adjusted basis, a move typically associated with maintaining exchange compliance and supporting marketability of the shares. Recent filings also point to segment reporting changes and ongoing restructuring efforts, indicating that the company remains in a turnaround or optimization phase rather than a stable mature growth cycle.
For investors, Greenlane should be viewed as a niche small-cap distributor with a recognizable footprint in the U.S. cannabis-adjacent accessory market, but also one facing elevated execution risk, margin pressure, and liquidity sensitivity. Its appeal lies in its specialized product mix, established brand portfolio and distribution relationships, while its risk profile reflects the challenges of operating in a competitive, regulation-sensitive and highly cyclical end market.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 4.4 m USD | -85.6 m USD | -11.42 USD | 10-K |
| Dec 2024 | 13.3 m USD | -17.6 m USD | -14.56 USD | 10-K |
| Dec 2023 | 65.4 m USD | -32.2 m USD | -8.16 USD | 10-K |
| Dec 2022 | 137.1 m USD | -169.5 m USD | -22.51 USD | 10-K |
| Dec 2021 | 166.1 m USD | -30.6 m USD | -15.85 USD | 10-K/A |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.